Clinical trials
We offer patients emerging treatments for macular diseases
Browse a list of current, upcoming and previous clinical trials conducted through the Clinical Research Unit.
Enrolling and Upcoming Clinical Trials
| Trial | Condition | Details |
| BenoBio | Wet AMD | Find out more - recruitment opening soon Ethical approval Bellberry HREC 2024/ETH01779 |
| INSITE | Diabetic Macular Oedema |
Ethical approval HREC/94784/SVHM-2023-358921 |
| KIRIN AMD | Wet AMD |
Ethical approval HREC/103832/SVHM-2023-400811 |
| KIRIN DME | DME |
Ethical approval HREC/103584/SVHM-2023 |
| PHOENIX | Dry AMD - Geographic Atrophy |
Ethical approval HREC/99641/SVHM-2023-378051 |
| PORTAL | Wet AMD |
Ethical approval HREC/70305/SVHM-2021-264245 |
| POYANG | Myopic CNV |
Ethical approval HREC/101598/SVHM-2023 |
| VELODROME | Wet AMD |
Ethical approval HREC/69746/2020-001313-20 |
| VIVID WHITE | Glaucoma |
Ethics approval HREC/102954/SVHM-2023-400792(v2) |
| RADAR | Diabetic Eye Disease | Ethical approval HREC/13/SAC/92 |
| MacTel Project | MacTel |
Ethical approval HREC/16/POWH/215 |
Current clinical trials
- FURGGHORN (Wet AMD) - HREC/95605/SVHM-2023-367480
- GALE (Extension of OAKS) - HREC/77051/SVHM-2021-273676
- KIRIN (Wet AMD) - HREC/103832/SVHM-2023-400811
- PHOENIX (Dry AMD) - HREC/99641/SVHM-2023-378051
- PORTAL (Wet AMD) - HREC/70305/SVHM-2021-264245
- VELODROME (Wet AMD) - HREC/69746/2020-001313-20
- INSITE - HREC/94784/SVHM-2023-358921
- RADAR - HREC/13/SAC/92
- KIRIN (DME) - HREC/103584/SVHM-2023
- VIVID WHITE – HREC/102954/SVHM-2023-400792(v2)
- POYANG - Ethical approval HREC/101598/SVHM-2023
- QUASAR - HREC/97356/SVHM-2023-367440
Completed Clinical Trials
- HAWK (Wet AMD) - HREC/15/RPAH/167
- RIVAL (Wet AMD) - HREC/13/SHA/46
- FILLY (Dry AMD) - HREC/15/RPAH/394
- CHROMA (Dry AMD) - HREC/14/RPAH/287
- OMASPECT (Dry AMD) - HREC/16/POWH/543
- SEQUOIA (Wet AMD) - HREC/15/RPAH/347
- ARIES (Wet AMD) - HREC/15/RPAH/387
- Talon (Wet AMD) - HREC/53858/SVHM-2019
- PANDA (Wet AMD) - HREC/18/SVHM/251
- Lucerne (Wet AMD) - HREC/49517/SVHM-2019
- OAKS (Dry AMD) - HREC/18/SVHM/252
- MyLight (Wet AMD) - HREC/70671/SVHM-2021-263810
- Talon EXTN (Wet AMD) - HREC/67626/SVHM-2020-232811
- HORIZON (Dry AMD) - SVHM HREC 294/20
- AVONELLE-X (Extension of Lucerne) - HREC/72069/SVHM-2020-244368
- Archer Study (Dry AMD) - CALHN HREC 2021/HRE00112
- IONIS (Dry AMD) - HREC/50571/SVHM-2018
- OTX-TKI (Wet AMD) - HREC/52072/SVHM-2019
- PULSAR (Wet AMD) and PULSAR Ext (Wet AMD) - HREC/63698/SVHM-2020-213156
- SAPPHIRE (RVO) - HREC/17/POWH/178
- TOPAZ (RVO) - HREC/18/MH/103
- RAVEN (CRVO) - HREC/51264/SVHM-2019
- RIPPLE (RVO) - HREC/67565/SVHM-2020-226369
- BALATON (BRVO) - HREC/65076/SVHM-2020-230166
- COMINO (CRVO) - HREC/65387/SVHM-2020-219227
- NIRVO - HREC/61973/SVHM-2020
- AUSSIEDEX - HREC/16/RAH/250
- SwitchDMO Study - HREC/12/RPAH/547
- Genetic study of Diabetic Retinopathy - SESLHD HREC 08/213
- NIRD - HREC/14/RPAH/205
- Bevordex (DMO) - LNR/17/POWH/619
- Ladamo (DMO) - HREC/14/RPAH/204
- Kestrel (DMO) - HREC/18/SVHM/149
- RHINE (DMO) - HREC/18/SVHM/240
- RIPPLE (DMO) - HREC/67565/SVHM-2020-226369
- EXONATE (DMO) - Bellberry HREC 2020/ETH02613
- RHONE-X (DMO) - HREC/63535/SVHM-2020
- CANBERRA - HREC/68388/SVHM-2020-230633
- MacTel CNTF2 - HREC/13/RPAH/393
- MacTel Bilateral - SCGOPHCG HREC RGS0000004826
- Renexus - HREC/17/SVHM/192
Patient feedback
I was so happy with the whole team's service and with how kind everyone was at every visit. It felt like family and 'home'.
“I feel very honoured to be part of clinical trials helping find new medications for future patients...the research team provides a very high level of service to the patients involved.”
“My experience with the clinical trials team has been very good and I am very appreciative of the support that I received throughout my time with them.”
Hear more from our patients here.